Yuan Chen, Shan Gao, Minqiu Lu, Bin Chu, Lei Shi, Qiuqing Xiang, Lijuan Fang, Yuehua Ding, Mengzhen Wang, Xi Liu, Xin Zhao, Kai Sun and Li Bao
Department
Hematology Department, Beijing Jishuitan Hospital, Capital Medical
University, No. 31 East Xinjiekou Street, Xicheng District, Beijing,100035,
China
Corresponding Author: Ruiqing Xu
Published Date: 26 January 2024; Received Date: 01 January 2024
1.1. Backgrount:
At present, the application of heparin is becoming more and more
widespread, the problems arising from the use of heparin are gradually
exposed, and people are paying more and more attention to how to
use heparin safely. Heparin-induced thrombocytopenia is a disease of
thrombocytopenia caused by the use of heparin in the treatment process.
Although this type of disease is relatively rare in clinical, it can cause
dangerous situations.
1.2. Case presentation:
A 75-year-old man was admitted to the hospital due to a recurrence
of multiple myeloma. He had to undergo hemodialysis due to high
creatinine. During the dialysis, platelets drop to extremely low levels
and iliac vein thrombosis appeared. It was found that the patient used
heparin to seal the tube during dialysis, which resulted in the heparininduced thrombocytopenia. After stopping heparin and using alternative
anticoagulation, the patient’s platelet count recovered gradually.
1.3. Conclusions:
HIT is a relatively hidden but very dangerous disease, which requires
rapid and correct judgment and measures. When the patient has HIT and
the platelet is extremely reduced, after weighing the risk of thrombosis,
alternative anticoagulation can be performed. The drug, Argatroban, can
still exert an anticoagulation effect even when used in low doses.